Ambu A/S (AMBBY)
19.25
+0.63
(+3.38%)
USD |
OTCM |
Jun 03, 09:30
Ambu Total Assets (Quarterly): 1.021B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.021B |
December 31, 2023 | 1.015B |
September 30, 2023 | 971.43M |
June 30, 2023 | 995.82M |
March 31, 2023 | 1.015B |
December 31, 2022 | 1.008B |
September 30, 2022 | 953.62M |
June 30, 2022 | 971.69M |
March 31, 2022 | 983.96M |
December 31, 2021 | 963.20M |
September 30, 2021 | 895.51M |
June 30, 2021 | 890.89M |
March 31, 2021 | 838.21M |
December 31, 2020 | 833.53M |
September 30, 2020 | 776.70M |
June 30, 2020 | 735.57M |
March 31, 2020 | 707.12M |
December 31, 2019 | 701.64M |
September 30, 2019 | 667.93M |
June 30, 2019 | 663.76M |
March 31, 2019 | 663.94M |
December 31, 2018 | 652.90M |
September 30, 2018 | 658.77M |
June 30, 2018 | 654.76M |
March 31, 2018 | 677.81M |
Date | Value |
---|---|
December 31, 2017 | 664.26M |
September 30, 2017 | 395.70M |
June 30, 2017 | 384.73M |
March 31, 2017 | 360.13M |
December 31, 2016 | 359.93M |
September 30, 2016 | 355.78M |
June 30, 2016 | 336.42M |
March 31, 2016 | 349.84M |
December 31, 2015 | 332.66M |
September 30, 2015 | 339.99M |
June 30, 2015 | 343.96M |
March 31, 2015 | 343.72M |
December 31, 2014 | 344.01M |
September 30, 2014 | 348.93M |
June 30, 2014 | 361.14M |
March 31, 2014 | 354.45M |
December 31, 2013 | 352.04M |
September 30, 2013 | 335.08M |
June 30, 2013 | 340.48M |
March 31, 2013 | 344.05M |
December 31, 2012 | 173.57M |
September 30, 2012 | 164.32M |
June 30, 2012 | 168.83M |
March 31, 2012 | 169.68M |
December 31, 2011 | 164.14M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
663.76M
Minimum
Jun 2019
1.021B
Maximum
Mar 2024
880.55M
Average
924.56M
Median
Total Assets (Quarterly) Benchmarks
Genmab A/S | 5.306B |
Ascendis Pharma A/S | 866.62M |
Galecto Inc | 32.48M |
Evaxion Biotech AS | 22.65M |
IO Biotech Inc | 128.16M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 210.62M |
Shareholders Equity (Quarterly) | 810.79M |
Current Ratio | 2.528 |
Net Debt Paydown Yield | 0.89% |